SGRY

Surgery Partners Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth 4/10
  • Value 6/10
Surgery Partners sales and earnings growth
SGRY Growth
Neutral
  • Revenue Y/Y 6.24%
  • EPS Y/Y 54.14%
  • FCF Y/Y 14.04%
Surgery Partners gross and profit margin trends
SGRY Profitability
Neutral
  • Gross margin 23.10%
  • EPS margin -2.40%
  • ROIC 5Y 3.49%
Surgery Partners net debt vs free cash flow
SGRY Risk
Good
  • Debt / Equity 1.3
  • Debt / FCF 15.5
  • Interest coverage 0.8

Surgery Partners stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

More Medical Care Facilities stocks ↗